AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext

NCT01741194 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
418
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Cerecin